InvestorsHub Logo
Followers 53
Posts 3357
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Tuesday, 05/22/2018 6:38:38 PM

Tuesday, May 22, 2018 6:38:38 PM

Post# of 3283
NSCLC Exon mutations treated with checkpoint inhibitors have low outcomes, as Dr Heymach stated back in Sept.

https://meetinglibrary.asco.org/record/161103/abstract